{"id":69399,"date":"2025-06-19T09:49:59","date_gmt":"2025-06-19T13:49:59","guid":{"rendered":"https:\/\/www.med.unc.edu\/medicine\/?p=69399"},"modified":"2025-06-25T08:02:55","modified_gmt":"2025-06-25T12:02:55","slug":"christopher-dittus-completes-meaningful-lymphoma-study-he-started-as-a-fellow","status":"publish","type":"post","link":"https:\/\/www.med.unc.edu\/medicine\/news\/christopher-dittus-completes-meaningful-lymphoma-study-he-started-as-a-fellow\/","title":{"rendered":"Christopher Dittus Completes Meaningful Lymphoma Study He Started as a Fellow"},"content":{"rendered":"<p data-start=\"0\" data-end=\"348\"><img loading=\"lazy\" decoding=\"async\" class=\"size-thumbnail wp-image-47638 alignright\" src=\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/03\/dittus-cropped-1690x2048-1-150x150.jpg\" alt=\"dittus-cropped\" width=\"150\" height=\"150\" srcset=\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/03\/dittus-cropped-1690x2048-1-150x150.jpg 150w, https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/03\/dittus-cropped-1690x2048-1-600x600.jpg 600w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/>Christopher Dittus, DO, MPH, Associate Professor of Medicine and Clinical Director of the lymphoma program, is the senior author of a newly published study in the <em data-start=\"111\" data-end=\"143\">British Journal of Haematology<\/em> evaluating a novel treatment approach for aggressive adult T-cell leukemia\/lymphoma (ATLL), a rare and deadly subtype of non-Hodgkin lymphoma that primarily affects ethnic minority populations in the U.S. The trial, conceived by Dittus during his fellowship, sought to fill the critical gap in standard treatment strategies for aggressive ATLL.<\/p>\n<p data-start=\"350\" data-end=\"896\">The multicenter pilot study, conducted at sites in Boston and Miami, tested a combination of brentuximab vedotin with cyclophosphamide, doxorubicin, etoposide, and prednisone (BV-CHEP). Sixteen patients with aggressive ATLL were enrolled. Results showed an 87.5% response rate, including a 62.5% complete response rate. The median overall survival was 15.7 months. Notably, 5 patients underwent allogeneic stem cell transplant as consolidation, with 3 achieving long-term survival and an associated improvement in overall survival.<\/p>\n<p data-start=\"898\" data-end=\"1074\" data-is-last-node=\"\" data-is-only-node=\"\"><a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjh.20177\">Read the full study here.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Christopher Dittus, DO, MPH, Associate Professor of Medicine and Clinical Director of the lymphoma program, is the senior author of a newly published study in the British Journal of Haematology evaluating a novel treatment approach for aggressive adult T-cell leukemia\/lymphoma (ATLL), a rare and deadly subtype of non-Hodgkin lymphoma that primarily affects ethnic minority populations &hellip; <a href=\"https:\/\/www.med.unc.edu\/medicine\/news\/christopher-dittus-completes-meaningful-lymphoma-study-he-started-as-a-fellow\/\" aria-label=\"Read more about Christopher Dittus Completes Meaningful Lymphoma Study He Started as a Fellow\">Read more<\/a><\/p>\n","protected":false},"author":116983,"featured_media":47638,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"layout":"","cellInformation":"","apiCallInformation":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[520,2,92,583],"tags":[],"class_list":["post-69399","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-hematology","category-news","category-research","category-research-news","odd"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Christopher Dittus Completes Meaningful Lymphoma Study He Started as a Fellow | Department of Medicine<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.med.unc.edu\/medicine\/news\/christopher-dittus-completes-meaningful-lymphoma-study-he-started-as-a-fellow\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Christopher Dittus Completes Meaningful Lymphoma Study He Started as a Fellow | Department of Medicine\" \/>\n<meta property=\"og:description\" content=\"Christopher Dittus, DO, MPH, Associate Professor of Medicine and Clinical Director of the lymphoma program, is the senior author of a newly published study in the British Journal of Haematology evaluating a novel treatment approach for aggressive adult T-cell leukemia\/lymphoma (ATLL), a rare and deadly subtype of non-Hodgkin lymphoma that primarily affects ethnic minority populations &hellip; Read more\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.med.unc.edu\/medicine\/news\/christopher-dittus-completes-meaningful-lymphoma-study-he-started-as-a-fellow\/\" \/>\n<meta property=\"og:site_name\" content=\"Department of Medicine\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/UNCDeptMedicine\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-19T13:49:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-25T12:02:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/03\/dittus-cropped-1690x2048-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1690\" \/>\n\t<meta property=\"og:image:height\" content=\"2048\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Lillian Harbison\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@uncdeptmedicine\" \/>\n<meta name=\"twitter:site\" content=\"@uncdeptmedicine\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lillian Harbison\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/christopher-dittus-completes-meaningful-lymphoma-study-he-started-as-a-fellow\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/christopher-dittus-completes-meaningful-lymphoma-study-he-started-as-a-fellow\/\"},\"author\":{\"name\":\"Lillian Harbison\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/583f230c1448c20a7f8507f25c34980c\"},\"headline\":\"Christopher Dittus Completes Meaningful Lymphoma Study He Started as a Fellow\",\"datePublished\":\"2025-06-19T13:49:59+00:00\",\"dateModified\":\"2025-06-25T12:02:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/christopher-dittus-completes-meaningful-lymphoma-study-he-started-as-a-fellow\/\"},\"wordCount\":164,\"image\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/christopher-dittus-completes-meaningful-lymphoma-study-he-started-as-a-fellow\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/03\/dittus-cropped-1690x2048-1.jpg\",\"articleSection\":[\"Hematology\",\"News\",\"Research\",\"Research News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/christopher-dittus-completes-meaningful-lymphoma-study-he-started-as-a-fellow\/\",\"url\":\"https:\/\/www.med.unc.edu\/medicine\/news\/christopher-dittus-completes-meaningful-lymphoma-study-he-started-as-a-fellow\/\",\"name\":\"Christopher Dittus Completes Meaningful Lymphoma Study He Started as a Fellow | Department of Medicine\",\"isPartOf\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/christopher-dittus-completes-meaningful-lymphoma-study-he-started-as-a-fellow\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/christopher-dittus-completes-meaningful-lymphoma-study-he-started-as-a-fellow\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/03\/dittus-cropped-1690x2048-1.jpg\",\"datePublished\":\"2025-06-19T13:49:59+00:00\",\"dateModified\":\"2025-06-25T12:02:55+00:00\",\"author\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/583f230c1448c20a7f8507f25c34980c\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/christopher-dittus-completes-meaningful-lymphoma-study-he-started-as-a-fellow\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.med.unc.edu\/medicine\/news\/christopher-dittus-completes-meaningful-lymphoma-study-he-started-as-a-fellow\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/christopher-dittus-completes-meaningful-lymphoma-study-he-started-as-a-fellow\/#primaryimage\",\"url\":\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/03\/dittus-cropped-1690x2048-1.jpg\",\"contentUrl\":\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/03\/dittus-cropped-1690x2048-1.jpg\",\"width\":1690,\"height\":2048,\"caption\":\"dittus-cropped\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/christopher-dittus-completes-meaningful-lymphoma-study-he-started-as-a-fellow\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.med.unc.edu\/medicine\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Christopher Dittus Completes Meaningful Lymphoma Study He Started as a Fellow\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#website\",\"url\":\"https:\/\/www.med.unc.edu\/medicine\/\",\"name\":\"Department of Medicine\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.med.unc.edu\/medicine\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/583f230c1448c20a7f8507f25c34980c\",\"name\":\"Lillian Harbison\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/cf508b25f1a4b6cfd299cad04f9f23c1a5209708cf67893bec17599d8d00d461?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/cf508b25f1a4b6cfd299cad04f9f23c1a5209708cf67893bec17599d8d00d461?s=96&d=mm&r=g\",\"caption\":\"Lillian Harbison\"},\"url\":\"https:\/\/www.med.unc.edu\/medicine\/news\/author\/lilharbi\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Christopher Dittus Completes Meaningful Lymphoma Study He Started as a Fellow | Department of Medicine","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.med.unc.edu\/medicine\/news\/christopher-dittus-completes-meaningful-lymphoma-study-he-started-as-a-fellow\/","og_locale":"en_US","og_type":"article","og_title":"Christopher Dittus Completes Meaningful Lymphoma Study He Started as a Fellow | Department of Medicine","og_description":"Christopher Dittus, DO, MPH, Associate Professor of Medicine and Clinical Director of the lymphoma program, is the senior author of a newly published study in the British Journal of Haematology evaluating a novel treatment approach for aggressive adult T-cell leukemia\/lymphoma (ATLL), a rare and deadly subtype of non-Hodgkin lymphoma that primarily affects ethnic minority populations &hellip; Read more","og_url":"https:\/\/www.med.unc.edu\/medicine\/news\/christopher-dittus-completes-meaningful-lymphoma-study-he-started-as-a-fellow\/","og_site_name":"Department of Medicine","article_publisher":"https:\/\/www.facebook.com\/UNCDeptMedicine","article_published_time":"2025-06-19T13:49:59+00:00","article_modified_time":"2025-06-25T12:02:55+00:00","og_image":[{"width":1690,"height":2048,"url":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/03\/dittus-cropped-1690x2048-1.jpg","type":"image\/jpeg"}],"author":"Lillian Harbison","twitter_card":"summary_large_image","twitter_creator":"@uncdeptmedicine","twitter_site":"@uncdeptmedicine","twitter_misc":{"Written by":"Lillian Harbison","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.med.unc.edu\/medicine\/news\/christopher-dittus-completes-meaningful-lymphoma-study-he-started-as-a-fellow\/#article","isPartOf":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/christopher-dittus-completes-meaningful-lymphoma-study-he-started-as-a-fellow\/"},"author":{"name":"Lillian Harbison","@id":"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/583f230c1448c20a7f8507f25c34980c"},"headline":"Christopher Dittus Completes Meaningful Lymphoma Study He Started as a Fellow","datePublished":"2025-06-19T13:49:59+00:00","dateModified":"2025-06-25T12:02:55+00:00","mainEntityOfPage":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/christopher-dittus-completes-meaningful-lymphoma-study-he-started-as-a-fellow\/"},"wordCount":164,"image":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/christopher-dittus-completes-meaningful-lymphoma-study-he-started-as-a-fellow\/#primaryimage"},"thumbnailUrl":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/03\/dittus-cropped-1690x2048-1.jpg","articleSection":["Hematology","News","Research","Research News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.med.unc.edu\/medicine\/news\/christopher-dittus-completes-meaningful-lymphoma-study-he-started-as-a-fellow\/","url":"https:\/\/www.med.unc.edu\/medicine\/news\/christopher-dittus-completes-meaningful-lymphoma-study-he-started-as-a-fellow\/","name":"Christopher Dittus Completes Meaningful Lymphoma Study He Started as a Fellow | Department of Medicine","isPartOf":{"@id":"https:\/\/www.med.unc.edu\/medicine\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/christopher-dittus-completes-meaningful-lymphoma-study-he-started-as-a-fellow\/#primaryimage"},"image":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/christopher-dittus-completes-meaningful-lymphoma-study-he-started-as-a-fellow\/#primaryimage"},"thumbnailUrl":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/03\/dittus-cropped-1690x2048-1.jpg","datePublished":"2025-06-19T13:49:59+00:00","dateModified":"2025-06-25T12:02:55+00:00","author":{"@id":"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/583f230c1448c20a7f8507f25c34980c"},"breadcrumb":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/christopher-dittus-completes-meaningful-lymphoma-study-he-started-as-a-fellow\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.med.unc.edu\/medicine\/news\/christopher-dittus-completes-meaningful-lymphoma-study-he-started-as-a-fellow\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.med.unc.edu\/medicine\/news\/christopher-dittus-completes-meaningful-lymphoma-study-he-started-as-a-fellow\/#primaryimage","url":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/03\/dittus-cropped-1690x2048-1.jpg","contentUrl":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/03\/dittus-cropped-1690x2048-1.jpg","width":1690,"height":2048,"caption":"dittus-cropped"},{"@type":"BreadcrumbList","@id":"https:\/\/www.med.unc.edu\/medicine\/news\/christopher-dittus-completes-meaningful-lymphoma-study-he-started-as-a-fellow\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.med.unc.edu\/medicine\/"},{"@type":"ListItem","position":2,"name":"Christopher Dittus Completes Meaningful Lymphoma Study He Started as a Fellow"}]},{"@type":"WebSite","@id":"https:\/\/www.med.unc.edu\/medicine\/#website","url":"https:\/\/www.med.unc.edu\/medicine\/","name":"Department of Medicine","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.med.unc.edu\/medicine\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/583f230c1448c20a7f8507f25c34980c","name":"Lillian Harbison","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/cf508b25f1a4b6cfd299cad04f9f23c1a5209708cf67893bec17599d8d00d461?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/cf508b25f1a4b6cfd299cad04f9f23c1a5209708cf67893bec17599d8d00d461?s=96&d=mm&r=g","caption":"Lillian Harbison"},"url":"https:\/\/www.med.unc.edu\/medicine\/news\/author\/lilharbi\/"}]}},"featured_image":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/03\/dittus-cropped-1690x2048-1.jpg","featured_image_medium":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/03\/dittus-cropped-1690x2048-1-248x300.jpg","featured_image_medium_large":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/03\/dittus-cropped-1690x2048-1-768x931.jpg","featured_image_large":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/03\/dittus-cropped-1690x2048-1-845x1024.jpg","featured_image_thumbnail":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2019\/03\/dittus-cropped-1690x2048-1-150x150.jpg","featured_image_alt":"dittus-cropped","category_details":[{"name":"Hematology","link":"https:\/\/www.med.unc.edu\/medicine\/news\/category\/hematology\/"},{"name":"News","link":"https:\/\/www.med.unc.edu\/medicine\/news\/category\/news\/"},{"name":"Research","link":"https:\/\/www.med.unc.edu\/medicine\/news\/category\/research\/"},{"name":"Research News","link":"https:\/\/www.med.unc.edu\/medicine\/news\/category\/research-news\/"}],"tag_details":[],"_links_to":[],"_links_to_target":[],"_links":{"self":[{"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/posts\/69399","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/users\/116983"}],"replies":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/comments?post=69399"}],"version-history":[{"count":2,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/posts\/69399\/revisions"}],"predecessor-version":[{"id":69413,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/posts\/69399\/revisions\/69413"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/media\/47638"}],"wp:attachment":[{"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/media?parent=69399"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/categories?post=69399"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/tags?post=69399"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}